Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|April 29, 2018
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral TherapyHawwa Alao, Maggie Cam, Chithra Keembiyehetty, et al.
Gastroenterology|September 22, 2010
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonrespondersJordan J Feld, Apurva A Modi, Ramy El-Diwany, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
The American Journal of Gastroenterology|June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CChihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.
The American Journal of Gastroenterology|February 2, 2023
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment TrialJordan J Feld, Abdus S Wahed, Michael Fried, et al.
Gastroenterology|March 10, 2010
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patientsHsin-Ni Liu, Elena Kim, Zhili Wang, et al.
Hepatology (Baltimore, Md.)|December 15, 2018
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus InfectionJordan J Feld, Norah A Terrault, Hsing-Hua S Lin, et al.
The American Journal of Gastroenterology|April 1, 2006
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trialRobert J Fontana, Arun J Sanyal, Savant Mehta, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|April 29, 2018
Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral TherapyHawwa Alao, Maggie Cam, Chithra Keembiyehetty, et al.
Gastroenterology|September 22, 2010
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonrespondersJordan J Feld, Apurva A Modi, Ramy El-Diwany, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
The American Journal of Gastroenterology|June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CChihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.
The American Journal of Gastroenterology|February 2, 2023
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment TrialJordan J Feld, Abdus S Wahed, Michael Fried, et al.
Gastroenterology|March 10, 2010
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patientsHsin-Ni Liu, Elena Kim, Zhili Wang, et al.
Hepatology (Baltimore, Md.)|December 15, 2018
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus InfectionJordan J Feld, Norah A Terrault, Hsing-Hua S Lin, et al.
The American Journal of Gastroenterology|April 1, 2006
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trialRobert J Fontana, Arun J Sanyal, Savant Mehta, et al.
Pageof 19